Clinical Trials Browser

Interventional × Estrogen Receptor-positive Breast Cancer × Letrozole × Clear all

NCT03962647 2024-10-15

A 2-Week Ketogenic Diet in Combination With Letrozole to Modulate PI3K Signaling in ER+ Breast Cancer

Phase EARLY_PHASE1 Completed

Estrogen Receptor-positive Breast Cancer

NCT03633331 2021-10-15

Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer

Phase 2 Unknown

93 enrolled 8 charts

Estrogen Receptor-positive Breast Cancer